News
Popular searches: Influenza, Childhood cancer, Endometriosis, Inflammation
-
Engineering a better POP treatment option
People living with pelvic organ prolapse (POP) have had a limited number of treatments available to them over the years, so a new POP treatment option can be a cause for excitement.… Read more
-
Introducing POP advocate – Sally Maconochie
It’s a condition that is rarely spoken about, but one Australian woman has set out to change that – meet Hudson Institute’s new pelvic organ prolapse (POP) advocate, Sally Maconochie.… Read more
-
Big ideas attract big funding
Hudson Institute researchers have featured prominently among the latest recipients of NHMRC Ideas Grants.… Read more
-
Refining how doctors assess hypertension risk
They’ve already identified a major undiagnosed cause of hypertension (high blood pressure), now the same team of researchers is helping doctors to better assess hypertension risk.… Read more
-
Professor Hartland appointed AAMRI President Elect
Hudson Institute’s Director and CEO, Professor Elizabeth Hartland, has been appointed the President Elect for the Association of Australian Medical Research Institutes (AAMRI). Professor Hartland will advance from her current roles as a member of the Board and the Chair of the Victorian branch of AAMRI, to take on the national leadership as President in 2023.… Read more
-
Rock star scientist announced as a Superstar of STEM
A microbial mastermind and rock star scientist from Hudson Institute has today been announced as one of Australia’s newest Superstars of STEM.… Read more
-
Finding the source of the body’s protection against STIs
The body’s first line of defence against infection is now better understood, with researchers at Hudson Institute identifying a source of the immune system’s protection against STIs (sexually transmitted infections).… Read more
-
New hope for treating neonatal seizures
Trials of an anti-seizure drug in newborns are showing great promise, giving researchers new hope for treating neonatal seizures and preventing their devastating consequences.… Read more
-
Beating antimicrobial resistance
A leader in the fight against one of the world’s most urgent medical problems, beating antimicrobial resistance (AMR) has been granted $1.375 million over five years from a local philanthropist to progress her work.… Read more
-
Pioneering work attracts VCA cancer fellowships
Two Hudson Institute researchers at different stages of their careers have won sought-after Victorian Cancer Agency (VCA) Fellowships. Blood cancer specialist Dr Catherine Carmichael received the VCA Mid-Career Research Fellowship for her research into Acute Myeloid Leukaemia (AML), while Dr Claire Sun was awarded the VCA Early Career Research Fellowship to further her search for… Read more